By Counterforce Health Team in Kanuma (sebelipase alfa) —

How to Get Kanuma (Sebelipase Alfa) Covered by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Kanuma Covered by Aetna CVS Health in Georgia

Yes, Aetna CVS Health covers Kanuma (sebelipase alfa) in Georgia with prior authorization. Submit your PA request through the Availity provider portal at least two weeks before treatment. You'll need confirmed LAL-D diagnosis (enzyme testing + LIPA gene sequencing), baseline labs, and clinical documentation. If denied, file an internal appeal within 60 days, then request Georgia DOI external review within 60 days of final denial. Start today: Gather your enzyme test results, genetic testing, and baseline liver function labs.

Table of Contents

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Aetna plans Availity provider portal Aetna 2024 Precert List
Diagnosis Confirmation LAL enzyme <10% normal + LIPA gene variants Lab reports, genetic testing FDA Access Data
Site of Care Hospital/infusion center only (no home admin) Aetna infusion policy Aetna Site of Care Policy
Appeals Deadline 60 days for internal, 60 days for GA external review Georgia DOI Consumer Services GA Insurance Code

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis Documentation

Who: Your metabolic specialist or geneticist
What: LAL enzyme activity test showing <10% of normal activity and LIPA gene sequencing confirming pathogenic variants
Timeline: Complete before PA submission
Source: Mayo Clinic Labs LAL-D testing

2. Gather Baseline Clinical Evidence

Who: Your care team
What: Liver function panel (ALT ≥1.5x upper limit normal on two occasions), lipid profile, growth parameters (pediatric), imaging if available
Timeline: Within 30 days of PA submission

3. Submit Prior Authorization

Who: Your prescribing physician or specialty pharmacy
What: Complete PA form with all supporting documentation
How: Availity provider portal
Timeline: Submit 2+ weeks before planned treatment start

4. Select Approved Infusion Site

Who: Patient/care team
What: Choose in-network hospital outpatient or certified infusion center
Why: Kanuma requires monitored administration due to anaphylaxis risk

5. Track Your Request

Who: Patient or care team
What: Follow up if no response within 14 business days
How: Call Aetna member services or provider line

6. Prepare for Potential Appeal

Who: Patient and prescriber
What: If denied, gather additional evidence and prepare appeal documentation
Timeline: Must file within 60 days of denial

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
"Insufficient diagnostic evidence" Submit complete enzyme + genetic testing LIPA gene sequencing report with pathogenic variants
"Not medically necessary" Provide clinical progression evidence Serial liver function tests, growth charts, specialist notes
"Experimental/investigational" Cite FDA approval for LAL-D FDA label showing approved indication
"Non-formulary status" Request formulary exception Medical necessity letter + prior therapy documentation
From Our Advocates: We've seen LAL-D patients initially denied for "insufficient documentation" get approved after submitting both the enzyme activity results AND genetic testing together. Many providers submit only one test initially, but Aetna typically wants both to confirm the diagnosis definitively.

Appeals Playbook for Georgia

Internal Appeal with Aetna CVS Health

  • Deadline: 60 days from denial date
  • How to File: Submit through member portal or call member services
  • Timeline: Standard review within 30-45 days, expedited within 72 hours
  • Required: Original denial letter, additional medical evidence, prescriber support letter

Georgia DOI External Review

If your internal appeal fails, Georgia offers binding external review:

Key Point: Georgia's external review applies to fully insured plans. If you have employer coverage, verify with HR that your plan isn't self-funded (ERISA), which may not be eligible.

For assistance navigating complex coverage challenges like these, Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned to payers' own rules.

Clinician Corner: Medical Necessity Documentation

Essential Elements for Your Medical Necessity Letter:

Diagnosis Confirmation:

  • LAL enzyme activity <10% of normal (include specific lab values and reference ranges)
  • LIPA gene variants classified as pathogenic or likely pathogenic per ACMG criteria

Clinical Severity Evidence:

  • Hepatomegaly documentation (imaging, physical exam)
  • Elevated liver enzymes (ALT ≥1.5x ULN on two occasions minimum)
  • Dyslipidemia (LDL-C, triglycerides, HDL-C levels)
  • Growth parameters if pediatric patient

Treatment Rationale:

  • Reference FDA-approved indication for LAL-D
  • Note lack of alternative FDA-approved therapies
  • Explain inadequacy of supportive care alone (lipid-lowering agents, dietary management)

Monitoring Plan:

  • Specify infusion site with emergency capabilities
  • Outline response monitoring (liver enzymes, lipids, growth)

Costs & Financial Assistance

Kanuma is extremely expensive, with annual costs ranging from $890,000 to $4.9 million depending on patient weight and dosing requirements. Financial assistance options include:

Manufacturer Support

  • Alexion OneSource: Case management and insurance navigation
  • Copay assistance: For commercially insured patients (verify eligibility)
  • Contact: alexiononesource.com/kanuma

Foundation Grants

  • HealthWell Foundation
  • Patient Access Network (PAN) Foundation
  • National Organization for Rare Disorders (NORD)

When dealing with high-cost specialty medications like Kanuma, having expert support can make the difference between approval and denial. Counterforce Health specializes in helping patients get prescription drugs approved by turning insurance denials into targeted appeals backed by the right clinical evidence and payer-specific documentation.

FAQ

Q: How long does Aetna CVS Health prior authorization take for Kanuma in Georgia? A: Standard PA review takes 14-30 business days. Expedited requests (for urgent medical need) are processed within 72 hours.

Q: What if Kanuma isn't on Aetna's formulary? A: Request a formulary exception by demonstrating medical necessity and lack of formulary alternatives. Include documentation that supportive therapies are inadequate.

Q: Can I get expedited review for my child with LAL-D? A: Yes, if your physician documents that delays pose serious health risks. Aetna processes expedited reviews within 72 hours.

Q: What happens if I miss the 60-day appeal deadline in Georgia? A: You may lose your right to external review. Contact Georgia DOI Consumer Services immediately to discuss options.

Q: Does step therapy apply to Kanuma? A: Generally no, since Kanuma is the only FDA-approved enzyme replacement therapy for LAL-D. However, insurers may require documentation of failed supportive care.

Q: Can I appeal while continuing treatment? A: If you're already on Kanuma, continuation of therapy during appeal may be possible. Contact your insurer about continuation of benefits policies.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your insurer and consult your healthcare provider for medical decisions. For personalized assistance with insurance appeals and coverage challenges, contact Georgia DOI Consumer Services at 1-800-656-2298.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.